Your new experience awaits. Try the new design now and help us make it even better

EDITORIAL article

Front. Immunol., 15 August 2025

Sec. Mucosal Immunity

Volume 16 - 2025 | https://doi.org/10.3389/fimmu.2025.1672088

This article is part of the Research TopicUnveiling the Host's Acute Immune Response to Infectious Mucosal Diseases: Insights and ImplicationsView all 5 articles

Editorial: Unveiling the host’s acute immune response to infectious mucosal diseases: insights and implications

  • 1Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, VA, United States
  • 2Department of Molecular Biosciences, The Wenner-Gren Institute (MBW), Stockholm University, Stockholm, Sweden
  • 3Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, VA, United States

Innate immunity constitutes the body’s first line of defense, acting with remarkable specificity and speed in response to microbial threats. Once considered a blunt instrument of host defense, the innate immune system is now recognized as highly nuanced, capable of immunological memory, developmental crosstalk, and tissue-specific modulation (1, 2). The contributions in this Research Topic reflect the growing appreciation of innate immune complexity across diverse systems and life stages, from bacterial infection to tissue repair and early-life development.

The study by Toapanta et al. employs a Controlled Human Infection Model (CHIM) with Salmonella Typhi to reveal distinct alterations in monocyte subsets during infection. Classical and intermediate monocytes in individuals who reached typhoid diagnosis criteria (TD) upregulated pattern recognition receptors (TLR4, TLR5), phagocytic markers (CD36, CD206), and gut-homing integrins (α4β7). These findings resonate with prior studies showing monocytes as dynamic responders capable of migrating to mucosal tissues and differentiating into effector macrophages (3, 4). The observed expansion of activated CM clusters suggests that monocytes may act not only as precursors to intestinal macrophages but also as immune amplifiers during systemic infection, shaping both innate and adaptive responses (5).

Extending the role of non-traditional immune cells, Xiao et al. present compelling evidence that red blood cells (RBCs), long considered immunologically inert, express surface TLR9 capable of binding mitochondrial DNA (mtDNA). Their data show that in bacterial infections, the number of mtDNA bound to RBCs increases significantly and correlates with C-reactive protein (CRP) levels, a marker of systemic inflammation. This aligns with emerging views that extracellular mtDNA is a potent damage-associated molecular pattern (DAMP) capable of triggering TLR9 and cGAS-STING pathways (6, 7). The discovery that RBCs may act as immune sentinels through TLR9 expands their functional repertoire and opens new avenues for biomarker development in infectious diseases.

In contrast to these inflammation-driven responses, Soma et al. propose a beneficial immune modulation model via mucosal administration of lipopolysaccride (LPS). Traditionally viewed as an endotoxin that drives sepsis when administered systemically (8), LPS can have markedly different effects when delivered orally or transdermally. The authors introduce the “macrophage network,” a framework wherein environmental LPS primes mucosal macrophages, which in turn communicate with distal tissue-resident macrophages through juxtacrine signaling. This hypothesis resonates with prior findings that low-dose LPS exposure can induce endotoxin tolerance and protective effects (9, 10). Their review article reframes LPS not as a uniform danger signal but as a context-dependent modulator of immune tone and tissue homeostasis.

Complementing these findings, Sharafian et al. utilize infant-derived ileal enteroids to explore how innate cytokines shape epithelial maturation. Their model reveals that IL-22, secreted by neonatal Th17 cells, drives epithelial proliferation and secretory differentiation while downregulating Wnt and Notch pathways. These results support a growing body of literature positioning IL-22 as a central regulator of mucosal barrier integrity and antimicrobial defense (Sharafian et al., 11, 12). The findings also reinforce the developmental specificity of immune–epithelial crosstalk, with early-life cytokines serving dual roles in tissue formation and immune readiness.

Together, these studies underscore the functional plasticity of the innate immune system. From circulating monocytes and epithelial crosstalk to erythrocyte surveillance and macrophage conditioning, innate immunity emerges as a finely tuned network capable of integrating microbial, developmental, and environmental signals. These insights challenge traditional compartmentalizations of immune cell function and suggest that innate cells operate not just as pathogen destroyers but as orchestrators of homeostasis, repair, and long-term immunity (13).

We thank all contributors to this Research Topic for their high-quality work. Their findings not only expand the functional map of innate immunity but also offer translational potential from infection biomarkers and vaccine design to mucosal therapies and early-life interventions. As the field continues to move beyond static classifications, future studies will benefit from high-resolution tools such as single-cell transcriptomics, spatial mapping, and in vivo imaging to further decode the cellular choreography of innate immunity in health and disease.

Author contributions

MA: Writing – review & editing, Writing – original draft. CF: Writing – review & editing. FN: Writing – original draft, Writing – review & editing.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Netea MG, Joosten LA, Latz E, Mills KH, Natoli G, Stunnenberg HG, et al. Trained immunity: A program of innate immune memory in health and disease. Science. (2016) 352:aaf1098. doi: 10.1126/science.aaf1098

PubMed Abstract | Crossref Full Text | Google Scholar

2. Iwasaki A and Medzhitov R. Control of adaptive immunity by the innate immune system. Nat Immunol. (2015) 16:343–53. doi: 10.1038/ni.3123

PubMed Abstract | Crossref Full Text | Google Scholar

3. Varol C, Landsman L, Fogg DK, Greenshtein L, Gildor B, Margalit R, et al. Monocytes give rise to mucosal, but not splenic, conventional dendritic cells. J Exp Med. (2007) 204:171–80. doi: 10.1084/jem.20061011

PubMed Abstract | Crossref Full Text | Google Scholar

4. Guilliams M, Mildner A, and Yona S. Developmental and functional heterogeneity of monocytes. Immunity. (2018) 49:595–613. doi: 10.1016/j.immuni.2018.10.005

PubMed Abstract | Crossref Full Text | Google Scholar

5. Shi C and Pamer EG. Monocyte recruitment during infection and inflammation. Nat Rev Immunol. (2011) 11:762–74. doi: 10.1038/nri3070

PubMed Abstract | Crossref Full Text | Google Scholar

6. West AP and Shadel GS. Mitochondrial DNA in innate immune responses and inflammatory pathology. Nat Rev Immunol. (2017) 17:363–75. doi: 10.1038/nri.2017.21

PubMed Abstract | Crossref Full Text | Google Scholar

7. Zhang Q, Itagaki K, and Hauser CJ. Mitochondrial DNA is released by shock and activates neutrophils via P38 map kinase. Shock. (2010) 34:55–9. doi: 10.1097/SHK.0b013e3181cd8c08

PubMed Abstract | Crossref Full Text | Google Scholar

8. Beutler B, Milsark IW, and Cerami AC. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. (1985) 229:869–71. doi: 10.1126/science.3895437

PubMed Abstract | Crossref Full Text | Google Scholar

9. Medzhitov R, Schneider DS, and Soares MP. Disease tolerance as a defense strategy. Science. (2012) 335:936–41. doi: 10.1126/science.1214935

PubMed Abstract | Crossref Full Text | Google Scholar

10. Vatanen T, Kostic AD, d'Hennezel E, Siljander H, Franzosa EA, Yassour M, et al. Variation in microbiome lps immunogenicity contributes to autoimmunity in humans. Cell. (2016) 165:842–53. doi: 10.1016/j.cell.2016.04.007

PubMed Abstract | Crossref Full Text | Google Scholar

11. Lindemans CA, Calafiore M, Mertelsmann AM, O'Connor MH, Dudakov JA, Jenq RR, et al. Interleukin-22 promotes intestinal-stem-cell-mediated epithelial regeneration. Nature. (2015) 528:560–4. doi: 10.1038/nature16460

PubMed Abstract | Crossref Full Text | Google Scholar

12. Sonnenberg GF, Fouser LA, and Artis D. Border patrol: regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by il-22. Nat Immunol. (2011) 12:383–90. doi: 10.1038/ni.2025

PubMed Abstract | Crossref Full Text | Google Scholar

13. Ginhoux F and Guilliams M. Tissue-resident macrophage ontogeny and homeostasis. Immunity. (2016) 44:439–49. doi: 10.1016/j.immuni.2016.02.024

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: infection - immunology, Salmonella Typhi (S Typhi), TLR4, TLR5, macrophages, RBC (red-blood-cell), TLR9, LPS

Citation: Arish M, Fernández C and Naz F (2025) Editorial: Unveiling the host’s acute immune response to infectious mucosal diseases: insights and implications. Front. Immunol. 16:1672088. doi: 10.3389/fimmu.2025.1672088

Received: 23 July 2025; Accepted: 05 August 2025;
Published: 15 August 2025.

Edited and reviewed by:

Alister Curtis Ward, Deakin University, Australia

Copyright © 2025 Arish, Fernández and Naz. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Farha Naz, eW13NHh3QHZpcmdpbmlhLmVkdQ==; ZmFyaGE2NEBnbWFpbC5jb20=

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.